Nevertheless, miR-328-3p also modulates the expression of other cancer-related genes, including SLC2A1, and synergistically inhibits cancer cell proliferation with chemotherapeutics (Yi et al., 2020) (Table 3). This evidence concerns the gene SLC2A1 and cancer.